| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,295 | 11,568 | 12,485 | 12,089 | | Cost of Revenue | 2,370 | 2,539 | 2,696 | 2,994 | | | Gross Profit |
-
| 9,029 | 9,789 | 9,095 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,341 | 7,133 | 6,280 | 5,951 | | Non Recurring | 1,160 | 16,154 |
-
|
-
| | Others | 30 | 14,346 | 1,064 | 3,547 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (28,604) | 2,445 | (403) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,394 | (28,604) | 2,445 | (403) | | Interest Expense | 1,355 | 1,495 | 1,768 | 1,903 | | Income Before Tax | 1,039 | (30,099) | 677 | (2,306) | | Income Tax Expense | 82 | (5,229) | 54 | (954) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 957 | (24,870) | 623 | (1,352) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 957 | (24,870) | 623 | (1,352) | | Preferred Stock And Other Adjustments | (265) | (91) |
-
|
-
| | | Net Income Applicable To Common Shares | $692 | ($24,961) | $623 | ($1,352) |
|
0.01% Nasdaq 0.00%
Income Statement
